SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Alexion Pharmaceuticals, Inc. (ALXN) -- Ignore unavailable to you. Want to Upgrade?


To: Miljenko Zuanic who wrote (224)8/30/2002 2:14:04 PM
From: Biomaven  Read Replies (1) | Respond to of 824
 
Note that Neurogen has an active small molecule C5a antagonist program:

neurogen.com

I still do own a little ALXN - too cheap to sell. <g>

Be nice to know when they anticipate releasing results.

Peter